ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $45,654 | -71.9% | 11,135 | -75.5% | 0.00% | 0.0% |
| Q4 2021 | $162,564 | +5.7% | 45,536 | +7.8% | 0.00% | 0.0% |
| Q3 2021 | $153,790 | -0.4% | 42,250 | +19.3% | 0.00% | 0.0% |
| Q2 2021 | $154,401 | -17.3% | 35,413 | -22.0% | 0.00% | -33.3% |
| Q1 2021 | $186,705 | +0.6% | 45,427 | -2.3% | 0.00% | 0.0% |
| Q4 2020 | $185,535 | +44.3% | 46,500 | -2.4% | 0.00% | +50.0% |
| Q3 2020 | $128,577 | -13.0% | 47,621 | -11.4% | 0.00% | -33.3% |
| Q2 2020 | $147,777 | +17.4% | 53,737 | +0.7% | 0.00% | 0.0% |
| Q1 2020 | $125,880 | -49.1% | 53,339 | +1.3% | 0.00% | -25.0% |
| Q4 2019 | $247,380 | +101.3% | 52,634 | +43.2% | 0.00% | +100.0% |
| Q3 2019 | $122,912 | -27.3% | 36,745 | -28.5% | 0.00% | -33.3% |
| Q2 2019 | $168,997 | +8.6% | 51,367 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $155,642 | +10.9% | 51,367 | -0.5% | 0.00% | 0.0% |
| Q4 2018 | $140,385 | -19.0% | 51,612 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $173,416 | -99.9% | 51,612 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $133,159,000 | +166.2% | 51,612 | +127.0% | 0.00% | +100.0% |
| Q1 2018 | $50,021,000 | +56103.4% | 22,737 | -49.3% | 0.00% | 0.0% |
| Q4 2017 | $89,000 | -73.4% | 44,868 | -56.7% | 0.00% | -50.0% |
| Q3 2017 | $335,000 | 0.0% | 103,529 | -0.4% | 0.00% | 0.0% |
| Q2 2017 | $335,000 | +137.6% | 103,987 | -10.8% | 0.00% | +100.0% |
| Q4 2015 | $141,000 | -28.1% | 116,522 | +1.2% | 0.00% | 0.0% |
| Q3 2015 | $196,000 | +62.0% | 115,142 | +97.5% | 0.00% | 0.0% |
| Q2 2015 | $121,000 | -55.4% | 58,290 | -41.7% | 0.00% | -50.0% |
| Q1 2015 | $271,000 | +5.0% | 100,060 | -0.4% | 0.00% | 0.0% |
| Q4 2014 | $258,000 | +40.2% | 100,490 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $184,000 | +80.4% | 100,490 | +164.3% | 0.00% | 0.0% |
| Q2 2014 | $102,000 | -68.3% | 38,025 | -58.7% | 0.00% | -50.0% |
| Q1 2014 | $322,000 | -21.8% | 92,043 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $412,000 | +13.2% | 92,043 | +2.6% | 0.00% | 0.0% |
| Q3 2013 | $364,000 | -4.7% | 89,720 | -2.4% | 0.00% | 0.0% |
| Q2 2013 | $382,000 | – | 91,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |